Sun Pharma Industries receives Warning Letter for Halol facility

Last Updated : Dec 21 2015 | 12:01 AM IST

From USFDA

Sun Pharma Industries announced that it has received a Warning Letter from the US FDA as a result of the September 2014 inspection, for its facility located at Halol, Gujarat in India.

Powered by Capital Market - Live News

Connect with us on WhatsApp

Outcome of board meeting of Goldcoin Health Foods

Zee Learn allots equity shares

Gujarat State Petronet to acquire 13.71% stake in Sabarmati Gas

Board of UltraTech Cement approves change in directorate

First Published: Dec 19 2015 | 2:48 PM IST

Explore News

Stock Market LIVE
Stocks to Watch Today
Market Today
Latest News LIVE
Capital Infra Trust IPO
Delhi Elections 2025 Date
Quadrant Future Tek IPO
HMPV cases LIVE updates
IPO News
Business Standard at 50